Autopsy report · NCT00585312
Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)
Cause of deathNo reason given
“See termination reason in detailed description.”
Life of this trial
- Registered 1 year 4 months after it had already started.
- Ran for about 7 years 1 month before it stopped.
- 106 participants enrolled.
- Results were posted on the registry 1 year 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Sponsor type
- Industry
- Conditions
- Adenomatous Polyposis Coli
- Interventions
- Celecoxib; Placebo
- Participants
- 106
- Sites
- 42
- Countries
- Belgium, Czechia, Hong Kong, Hungary, Israel, Italy, Puerto Rico, Slovakia, South Africa, Spain, Sweden, Ukraine and more
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.